불안 관련 장애의 신경생물학적 이해

키워드

참고문헌 (113)

1. Charney D, "Neuropsychopharmacology: The Fifth Generation of Progress" (2002), Lippincott Williams & Wilkins
2. Schatzberg AF, "Textbook of Psychopharmacology" (2004), The American Psychiatric Publishing
3. Izard CE, "Four systems for emotion activation : cognitive and noncognitive processes", Psychol Rev, 100, pp.68~90 (1993)
4. LeDoux JE, "Emotion : clues from the brain", Annu Rev Psychol, 46, pp.209~235 (1995)
5. Stratakis CA, "Neuroendocrinology and pathophysiology of the stress system", Ann N Y Acad Sci, 771, pp.1~18 (1995)
6. Sorrells SF, "An inflammatory review of glucocorticoid actions in the CNS", Brain Behav Immun, 21, pp.259~272 (2007)
7. Eggers AE, "Redrawing Papez’ circuit : a theory about how acute stress becomes chronic and causes disease", Med Hypotheses, 69, pp.852~857 (2007)
8. Gray JA, "A theory of anxiety: the role of the limbic system", Encephale, 9(4 Suppl 2), pp.161~166B (1983)
9. Lilly R, "The human Klüver-Bucy syndrome", Neurology, 33, pp.1141~1145 (1983)
10. Maclean PD, "The limbic system(visceral brain)in relation to central gray and reticulum of the brain stem; evidence of interdependence in emotional processes", Psychosom Med, 17, pp.355~366 (1955)
11. Keedwell PA, "The neural correlates of anhedonia in major depressive disorder", Biol Psychiatry, 58, pp.843~853 (2005)
12. 12)Drevets WC, "Neuroimaging and neuropathological studies of depression : implications for the cognitive-emotional features of mood disorders", Curr Opin Neurobiol, 11, pp.240~249 (2001)
13. Miller EK, "An integrative theory of prefrontal cortex function", Annu Rev Neurosci, 24, pp.167~202 (2001)
14. Vogt BA, "Functional heterogeneity in cingulate cortex : the anterior executive and posterior evaluative regions", Cereb Cortex, 2, pp.435~443 (1992)
15. Treede RD, "The cortical representation of pain", Pain, 79, pp.105~111 (1999)
16. Kent JM, "Molecular targets in the treatment of anxiety", Biol Psychiatry, 52, pp.1008~1030 (2002)
17. Martin EI, "The neurobiology of anxiety disorders : brain imaging, genetics, and psychoneuroendocrinology", Clin Lab Med, 30, pp.865~891 (2010)
18. LeDoux JE, "Emotion circuits in the brain", Annu Rev Neurosci, 23, pp.155~184 (2000)
19. Zald DH, "The human amygdala and the emotional evaluation of sensory stimuli", Brain Res Brain Res Rev, 41, pp.88~123 (2003)
20. Phelps EA, "Contributions of the amygdala to emotion processing : from animal models to human behavior", Neuron, 48, pp.175~187 (2005)
21. Quirk GJ, "Prefrontal mechanisms in extinction of conditioned fear", Biol Psychiatry, 60, pp.337~343 (2006)
22. Bedecs K, "Galanin--10 years with a neuroendocrine peptide", Int J Biochem Cell Biol, 27, pp.337~349 (1995)
23. Liu HX, "The participation of galanin in pain processing at the spinal level", Trends Pharmacol Sci, 23, pp.468~474 (2002)
24. Lang R, "The galanin peptide family : receptor pharmacology, pleiotropic biological actions, and implications in health and disease", Pharmacol Ther, 115, pp.177~207 (2007)
25. Gimpl G, "The oxytocin receptor system : structure, function, and regulation", Physiol Rev, 81, pp.629~683 (2001)
26. Meyer-Lindenberg A, "Impact of prosocial neuropeptides on human brain function", Prog Brain Res, 170, pp.463~470 (2008)
27. Egashira N, "Impaired social interaction and reduced anxiety-related behavior in vasopressin V1a receptor knockout mice", Behav Brain Res, 178, pp.123~127 (2007)
28. Kendler KS, "A developmental twin study of symptoms of anxiety and depression : evidence for genetic innovation and attenuation", Psychol Med, 38, pp.1567~1575 (2008)
29. Massana G, "Parahippocampal gray matter density in panic disorder : a voxel-based morphometric study", Am J Psychiatry, 160, pp.566~568 (2003)
30. Han DH, "Altered cingulate white matter connectivity in panic disorder patients", J Psychiatr Res, 42, pp.399~407 (2008)
31. Kim B, "Frontal white matter alterations in short-term medicated panic disorder patients without comorbid conditions: a diffusion tensor imaging study", PLoS One, 9, pp.95279~ (2014)
32. Kim B, "Comparison of panic disorder with and without comorbid major depression by using brain structural magnetic resonance imaging", Prog Neuropsychopharmacol Biol Psychiatry, 43, pp.188~196 (2013)
33. Pfleiderer B, "fMRI amygdala activation during a spontaneous panic attack in a patient with panic disorder", World J Biol Psychiatry, 8, pp.269~272 (2007)
34. Lee YS, "Decreased blood flow of temporal regions of the brain in subjects with panic disorder", J Psychiatr Res, 40, pp.528~534 (2006)
35. Engel K, "Neuroimaging in anxiety disorders", J Neural Transm, 116, pp.703~716 (2009)
36. Goddard AW, "Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder", Am J Psychiatry, 161, pp.2186~2193 (2004)
37. Ham BJ, "Decreased GABA levels in anterior cingulate and basal ganglia in medicated subjects with panic disorder : a proton magnetic resonance spectroscopy(1H-MRS)study", Prog Neuropsychopharmacol Biol Psychiatry, 31, pp.403~411 (2007)
38. Helton DR, "Anxiolytic and side-effect profile of LY354740 : a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors", J Pharmacol Exp Ther, 284, pp.651~660 (1998)
39. Cortese BM, "The role of glutamate in anxiety and related disorders", CNS Spectr, 10, pp.820~830 (2005)
40. Pull CB, "Pharmacotherapy of panic disorder", Neuropsychiatr Dis Treat, 4, pp.779~795 (2008)
41. Vaswani M, "Role of selective serotonin reuptake inhibitors in psychiatric disorders : a comprehensive review", Prog Neuropsychopharmacol Biol Psychiatry, 27, pp.85~102 (2003)
42. Schatzberg AF, "The American Psychiatric Publishing textbook of psychopharmacology" (2004), American Psychiatric Pub
43. Unschuld PG, "Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder", J Affect Disord, 105, pp.177~184 (2008)
44. Hettema JM, "A review and meta-analysis of the genetic epidemiology of anxiety disorders", Am J Psychiatry, 158, pp.1568~1578 (2001)
45. Choe AY, "Serotonergic genes(5-HTT and HTR1A)and separation life events : gene-byenvironment interaction for panic disorder", Neuropsychobiology, 67, pp.192~200 (2013)
46. Smoller JW, "The genetic basis of panic and phobic anxiety disorders", Am J Med Genet C Semin Med Genet, 148, pp.118~126 (2008)
47. Lesch KP, "Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region", Science, 274, pp.1527~1531 (1996)
48. Bryant RA, "Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder", Psychol Med, 38, pp.555~561 (2008)
49. Bryant RA, "Rostral anterior cingulate volume predicts treatment response to cognitive-behavioural therapy for posttraumatic stress disorder", J Psychiatry Neurosci, 33, pp.142~146 (2008)
50. Morey RA, "Neural systems for executive and emotional processing are modulated by symptoms of posttraumatic stress disorder in Iraq War veterans", Psychiatry Res, 162, pp.59~72 (2008)
51. Falconer E, "The neural networks of inhibitory control in posttraumatic stress disorder", J Psychiatry Neurosci, 33, pp.413~422 (2008)
52. Lyoo IK, "The neurobiological role of the dorsolateral prefrontal cortex in recovery from trauma. Longitudinal brain imaging study among survivors of the South Korean subway disaster", Arch Gen Psychiatry, 68, pp.701~713 (2011)
53. Strawn JR, "Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder", Depress Anxiety, 25, pp.260~271 (2008)
54. Pervanidou P, "Biology of post-traumatic stress disorder in childhood and adolescence", J Neuroendocrinol, 20, pp.632~638 (2008)
55. Marshall RD, "An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder", J Clin Psychopharmacol, 18, pp.10~18 (1998)
56. Yehuda R, "Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping", Biol Psychiatry, 59, pp.660~663 (2006)
57. Yehuda R, "Low urinary cortisol excretion in patients with posttraumatic stress disorder", J Nerv Ment Dis, 178, pp.366~369 (1990)
58. Olff M, "HPA-and HPT-axis alterations in chronic posttraumatic stress disorder", Psychoneuroendocrinology, 31, pp.1220~1230 (2006)
59. Bremner JD, "Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder", Am J Psychiatry, 154, pp.624~629 (1997)
60. Baker DG, "Plasma and cerebrospinal fluid interleukin-6concentrations in posttraumatic stress disorder", Neuroimmunomodulation, 9, pp.209~217 (2001)
61. Smith MA, "The corticotropin-releasing hormone test in patients with posttraumatic stress disorder", Biol Psychiatry, 26, pp.349~355 (1989)
62. Yehuda R, "The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder", Biol Psychiatry, 52, pp.393~403 (2002)
63. Raison CL, "When not enough is too much : the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders", Am J Psychiatry, 160, pp.1554~1565 (2003)
64. Segman RH, "Genetics of posttraumatic stress disorder", CNS Spectr, 8, pp.693~698 (2003)
65. Yehuda R, "Relationship of parental trauma exposure and PTSD to PTSD, depressive and anxiety disorders in offspring", J Psychiatr Res, 35, pp.261~270 (2001)
66. Yehuda R, "Childhood trauma and risk for PTSD : relationship to intergenerational effects of trauma, parental PTSD, and cortisol excretion", Dev Psychopathol, 13, pp.733~753 (2001)
67. Koenen KC, "A high risk twin study of combat-related PTSD comorbidity", Twin Res, 6, pp.218~226 (2003)
68. Stein MB, "Genetic and environmental influences on trauma exposure and posttraumatic stress disorder symptoms : a twin study", Am J Psychiatry, 159, pp.1675~1681 (2002)
69. Heils A, "Allelic variation of human serotonin transporter gene expression", J Neurochem, 66, pp.2621~2624 (1996)
70. Caspi A, "Influence of life stress on depression : moderation by a polymorphism in the 5-HTT gene", Science, 301, pp.386~389 (2003)
71. Eley TC, "Gene-environment interaction analysis of serotonin system markers with adolescent depression", Mol Psychiatry, 9, pp.908~915 (2004)
72. Kaufman J, "Social supports and serotonin transporter gene moderate depression in maltreated children", Proc Natl Acad Sci U S A, 101, pp.17316~17321 (2004)
73. Kendler KS, "The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression : a replication", Arch Gen Psychiatry, 62, pp.529~535 (2005)
74. Gillespie NA, "The relationship between stressful life events, the serotonin transporter(5-HTTLPR)genotype and major depression", Psychol Med, 35, pp.101~111 (2005)
75. Kaufman J, "Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children", Biol Psychiatry, 59, pp.673~680 (2006)
76. Grabe HJ, "Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden", Mol Psychiatry, 10, pp.220~224 (2005)
77. Kilpatrick DG, "The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults", Am J Psychiatry, 164, pp.1693~1699 (2007)
78. Stein MB, "Increased amygdala activation to angry and contemptuous faces in generalized social phobia", Arch Gen Psychiatry, 59, pp.1027~1034 (2002)
79. Evans KC, "A functional MRI study of amygdala responses to angry schematic faces in social anxiety disorder", Depress Anxiety, 25, pp.496~505 (2008)
80. Norbury R, "Functional magnetic resonance imaging study", Br J Psychiatry, 190, pp.531~532 (2007)
81. Lorberbaum JP, "Neural correlates of speech anticipatory anxiety in generalized social phobia", Neuroreport, 15, pp.2701~2705 (2004)
82. Kilts CD, "The neural correlates of social anxiety disorder and response to pharmacotherapy", Neuropsychopharmacology, 31, pp.2243~2253 (2006)
83. Stein MB, "Social anxiety disorder", Lancet, 371, pp.1115~1125 (2008)
84. Mikkelsen EJ, "School avoidance and social phobia triggered by haloperidol in patients with Tourette’s disorder", Am J Psychiatry, 138, pp.1572~1576 (1981)
85. Stein MB, "Anxiety disorders in patients with Parkinson’s disease", Am J Psychiatry, 147, pp.217~220 (1990)
86. Liebowitz MR, "Phenelzine vs atenolol in social phobia. A placebo-controlled comparison", Arch Gen Psychiatry, 49, pp.290~300 (1992)
87. Johnson MR, "Plasma and CSF HVA levels in panic patients with comorbid social phobia", Biol Psychiatry, 36, pp.425~427 (1994)
88. Tiihonen J, "Dopamine reuptake site densities in patients with social phobia", Am J Psychiatry, 154, pp.239~242 (1997)
89. Schneier FR, "Low dopamine D(2)receptor binding potential in social phobia", Am J Psychiatry, 157, pp.457~459 (2000)
90. Hood SD, "Dopaminergic challenges in social anxiety disorder : evidence for dopamine D3 desensitisation following successful treatment with serotonergic antidepressants", J Psychopharmacol, 24, pp.709~716 (2010)
91. Condren RM, "HPA axis response to a psychological stressor in generalised social phobia", Psychoneuroendocrinology, 27, pp.693~703 (2002)
92. Roelofs K, "Hypothalamus-pituitary-adrenal axis hyperresponsiveness is associated with increased social avoidance behavior in social phobia", Biol Psychiatry, 65, pp.336~343 (2009)
93. Martel FL, "Salivary cortisol levels in socially phobic adolescent girls", Depress Anxiety, 10, pp.25~27 (1999)
94. van Veen JF, "Elevated alpha-amylase but not cortisol in generalized social anxiety disorder", Psychoneuroendocrinology, 33, pp.1313~1321 (2008)
95. De Bellis MD, "Superior temporal gyrus volumes in pediatric generalized anxiety disorder", Biol Psychiatry, 51, pp.553~562 (2002)
96. Monk CS, "Ventrolateral prefrontal cortex activation and attentional bias in response to angry faces in adolescents with generalized anxiety disorder", Am J Psychiatry, 163, pp.1091~1097 (2006)
97. Mathew SJ, "orsolateral prefrontal cortical pathology in generalized anxiety disorder : a proton magnetic resonance spectroscopic imaging study", Am J Psychiatry, 161, pp.1119~1121 (2004)
98. Herry C, "Switching on and off fear by distinct neuronal circuits", Nature, 454, pp.600~606 (2008)
99. Izumi T, "Changes in amygdala neural activity that occur with the extinction of context-dependent conditioned fear stress", Pharmacol Biochem Behav, 90, pp.297~304 (2008)
100. Davis M, "Role of the amygdala in fear extinction measured with potentiated startle", Ann N Y Acad Sci, 985, pp.218~232 (2003)
101. Monk CS, "Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder", Arch Gen Psychiatry, 65, pp.568~576 (2008)
102. McClure EB, "fMRI predictors of treatment outcome in pediatric anxiety disorders", Psychopharmacology(Berl), 191, pp.97~105 (2007)
103. Whalen PJ, "A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder", Biol Psychiatry, 63, pp.858~863 (2008)
104. Nemeroff CB, "The role of GABA in the pathophysiology and treatment of anxiety disorders", Psychopharmacol Bull, 37, pp.133~146 (2003)
105. Nutt DJ, "Neurobiological mechanisms in generalized anxiety disorder", J Clin Psychiatry, 62(Suppl 11), pp.22~27 (2001)
106. Mathew SJ, "Open-label trial of riluzole in generalized anxiety disorder", Am J Psychiatry, 162, pp.2379~2381 (2005)
107. Pittenger C, "Riluzole in the treatment of mood and anxiety disorders", CNS Drugs, 22, pp.761~786 (2008)
108. Maron E, "SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder", Eur Arch Psychiatry Clin Neurosci, 254, pp.392~396 (2004)
109. -2 beta-carbomethoxy-3beta-(4-iodophenyl)tropane and single photon emission computed tomography, "Biol Psychiatry", 1998, 1090~1098
110. Pande AC, "Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder", Biol Psychiatry, 46, pp.860~862 (1999)
111. Sajdyk TJ, "Interactions between NPY and CRF in the amygdala to regulate emotionality", Neuropeptides, 38, pp.225~234 (2004)
112. Ninan PT, "Recent perspectives on the diagnosis and treatment of generalized anxiety disorder", Am J Manag Care, 7(11 Suppl), pp.S367~S376 (2001)
113. Hettema JM, "A population-based twin study of generalized anxiety disorder in men and women", J Nerv Ment Dis, 189, pp.413~420 (2001)